Surgery Medical News about Mesothelioma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
American Journal of Surgical Pathology , 10/27/09

Yuan Y et al. – The data suggest that tenascin–X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.

<< Previous
Are we doing too many surveillance colonoscopies on colonic...

Next >>
Restoration of pulmonary compliance after laparoscopic surgery...

Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09 Relevance Score: 90%

Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09 Relevance Score: 88%

Living with mesothelioma. A literature review
European Journal of Cancer Care, 10/27/09 Relevance Score: 87%

Filing for workers' compensation among Ontario cases of mesothelioma
Canadian Respiratory Journal, 10/26/09 Relevance Score: 85%

Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
Lung Cancer, 10/01/09 Relevance Score: 85%